Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Invivo Therapeutics Holdings Corp (NVIV)

0.5895   -0.011 (-1.75%) 10-23 22:42
Open: 0.62 Pre. Close: 0.6
High: 0.62 Low: 0.57
Volume: 3,991,742 Market Cap: 3M
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company's approach to treating acute SCIs is based on its investigational Neuro Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion and is intended to treat acute spinal cord injury. The Neuro-Spinal Scaffold consists of biocompatible and bioresorbable polymers, which include poly lactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL). The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program for chronic SCI.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.624 - 0.63 0.63 - 0.634
Low: 0.558 - 0.565 0.565 - 0.57
Close: 0.581 - 0.594 0.594 - 0.601

Technical analysis

as of: 2020-10-23 4:47:21 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.34     One year: 1.75
Support: Support1: 0.57    Support2: 0.47
Resistance: Resistance1: 1.14    Resistance2: 1.50
Pivot: 1.26
Moving Average: MA(5): 0.98     MA(20): 1.29
MA(100): 1.49     MA(250): 3.66
MACD: MACD(12,26): -0.13     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 9.02     %D(3): 10.05
RSI: RSI(14): 15.63
52-week: High: 16.20  Low: 0.57  Change(%): -95.6
Average Vol(K): 3-Month: 46458  10-Days: 221449

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NVIV has closed below the lower band by 11.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 195.9% wider than normal. The large width of the bands suggest high volatility as compared to NVIV's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Fri, 23 Oct 2020
The Daily Biotech Pulse: Gilead Gets Full Approval For Remdesivir, Akebia's Positive Readout, Foghorn IPO - Benzinga

Fri, 23 Oct 2020
The Forecast Just Changed on InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - The Oracle Dispatch

Thu, 22 Oct 2020
InVivo Therapeutics Holdings Corp. (NVIV) Plunges 47.33% on October 22 - Equities.com

Thu, 22 Oct 2020
Boiling and ready to burst as InVivo Therapeutics Holdings Corp. (NVIV) last month performance was -18.04% - The InvestChronicle

Thu, 22 Oct 2020
Mid-Day Market Update: Crude Oil Rises 2%; InVivo Therapeutics Shares Plummet - Benzinga

Thu, 22 Oct 2020
Is There a Dimmer Outlook Ahead for InVivo Therapeutics Holdings Corp. (NVIV)? - The News Heater

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 5
Shares Float (M) 5
% Held by Insiders 0.31
% Held by Institutions 16.41
Shares Short (K) 329
Shares Short P. Month (K) 292

Stock Financials

EPS -6.929
EPS Est This Year -0.780
EPS Est Next Year -0.640
Book Value (p.s.) 2.050
Profit Margin
Operating Margin
Return on Assets (ttm) -47.9
Return on Equity (ttm) -103.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.059
Qtrly Earnings Growth
Operating Cash Flow (M) -9
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -0.09
PEG Ratio
Price to Book value 0.29
Price to Sales
Price to Cash Flow -0.31

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.